HBIO
Price
$0.32
Change
+$0.01 (+3.33%)
Updated
May 9 closing price
Capitalization
184.01M
One day until earnings call
MMSI
Price
$95.83
Change
-$0.26 (-0.27%)
Updated
May 9 closing price
Capitalization
4.39B
74 days until earnings call
Ad is loading...

HBIO vs MMSI

Header iconHBIO vs MMSI Comparison
Open Charts HBIO vs MMSIBanner chart's image
Harvard Bioscience
Price$0.32
Change+$0.01 (+3.33%)
Volume$432.98K
Capitalization184.01M
Merit Medical Systems
Price$95.83
Change-$0.26 (-0.27%)
Volume$694.48K
Capitalization4.39B
HBIO vs MMSI Comparison Chart
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. MMSI commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and MMSI is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (HBIO: $0.31 vs. MMSI: $95.83)
Brand notoriety: HBIO and MMSI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 123% vs. MMSI: 88%
Market capitalization -- HBIO: $184.01M vs. MMSI: $4.39B
HBIO [@Medical Specialties] is valued at $184.01M. MMSI’s [@Medical Specialties] market capitalization is $4.39B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileMMSI’s FA Score has 1 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • MMSI’s FA Score: 1 green, 4 red.
According to our system of comparison, MMSI is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 3 TA indicator(s) are bullish while MMSI’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 3 bullish, 3 bearish.
  • MMSI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both HBIO and MMSI are a good buy in the short-term.

Price Growth

HBIO (@Medical Specialties) experienced а -9.40% price change this week, while MMSI (@Medical Specialties) price change was +0.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.40%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -3.53%.

Reported Earning Dates

HBIO is expected to report earnings on Aug 06, 2025.

MMSI is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical Specialties (-1.40% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMSI($4.39B) has a higher market cap than HBIO($184M). MMSI YTD gains are higher at: -0.920 vs. HBIO (-85.071). MMSI has higher annual earnings (EBITDA): 229M vs. HBIO (8.03M). MMSI has more cash in the bank: 587M vs. HBIO (4.28M). HBIO has less debt than MMSI: HBIO (42.8M) vs MMSI (891M). MMSI has higher revenues than HBIO: MMSI (1.26B) vs HBIO (112M).
HBIOMMSIHBIO / MMSI
Capitalization184M4.39B4%
EBITDA8.03M229M4%
Gain YTD-85.071-0.9209,245%
P/E RatioN/A46.44-
Revenue112M1.26B9%
Total Cash4.28M587M1%
Total Debt42.8M891M5%
FUNDAMENTALS RATINGS
HBIO vs MMSI: Fundamental Ratings
HBIO
MMSI
OUTLOOK RATING
1..100
570
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
1009
SMR RATING
1..100
9471
PRICE GROWTH RATING
1..100
9752
P/E GROWTH RATING
1..100
244
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMSI's Valuation (82) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that MMSI’s stock grew similarly to HBIO’s over the last 12 months.

MMSI's Profit vs Risk Rating (9) in the Medical Specialties industry is significantly better than the same rating for HBIO (100) in the Biotechnology industry. This means that MMSI’s stock grew significantly faster than HBIO’s over the last 12 months.

MMSI's SMR Rating (71) in the Medical Specialties industry is in the same range as HBIO (94) in the Biotechnology industry. This means that MMSI’s stock grew similarly to HBIO’s over the last 12 months.

MMSI's Price Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for HBIO (97) in the Biotechnology industry. This means that MMSI’s stock grew somewhat faster than HBIO’s over the last 12 months.

HBIO's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for MMSI (44) in the Medical Specialties industry. This means that HBIO’s stock grew somewhat faster than MMSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOMMSI
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with RVTY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
+3.41%
RVTY - HBIO
47%
Loosely correlated
-1.78%
TMO - HBIO
46%
Loosely correlated
-1.86%
ICUI - HBIO
46%
Loosely correlated
-3.20%
XRAY - HBIO
46%
Loosely correlated
-0.63%
CERS - HBIO
46%
Loosely correlated
-5.15%
More

MMSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMSI
1D Price
Change %
MMSI100%
-0.27%
BSX - MMSI
64%
Loosely correlated
-0.42%
ISRG - MMSI
55%
Loosely correlated
-0.31%
SYK - MMSI
53%
Loosely correlated
-0.40%
ATR - MMSI
44%
Loosely correlated
-0.03%
HBIO - MMSI
44%
Loosely correlated
+3.41%
More